According to a new report North America Contrast Media Market, published by KBV Research, the North America Contrast Media Market would witness market growth of 2.91% CAGR during the forecast period (2019-2025).
The USA market dominated the North America Barium-based Market by Country in 2018, and would continue to be a dominant market till 2025. The Canada market is anticipated to grow at a CAGR of 4.4% during (2019 - 2025). Additionally, The Mexico market would witness a CAGR of 6.3% during (2019 - 2025).
The Neurological disorders market dominated the Canada Contrast Media Market by Application in 2018, growing at a CAGR of 2.3 % during the forecast period. The Cancer market is witnessing a CAGR of 3.7% during (2019 - 2025). The Musculoskeletal disorders market is exhibiting a growth rate CAGR of 5% during (2019 - 2025).
The X-ray/CT market dominated the Mexico Contrast Media Market by Modality in 2018, thereby, achieving a market value of $123.3 million by 2025. The Ultrasound market is expected to witness a CAGR of 5.6% during (2019 - 2025).
Report Structural Insights: https://www.kbvresearch.com/north-america-contrast-media-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Bayer AG, General Electric (GE) Co. (GE Healthcare), The Guerbet Group, Lantheus Holdings, Inc., Bracco S.p.A., Trivitron Healthcare Pvt. Ltd., Nano Therapeutics Pvt. Ltd., Magnus Health, LLC (Veracross LLC), Imax Diagnostic Imaging Limited, and Daiichi Sankyo Company, Limited.
By Product Type
By Application
By Modality
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
